Abbott gets CE Mark for Navitor TAVI System to treat aortic stenosis
The new-generation TAVI system eliminates the risk of blood leakage around valve implant for patients with severe aortic…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 May 21
The new-generation TAVI system eliminates the risk of blood leakage around valve implant for patients with severe aortic…
07 Apr 21
EC approval is supported by the results from XIENCE 28 and XIENCE 90 clinical trials
29 Mar 21
Harmony TPV is designed to provide an alternative to the invasive open-heart surgery
15 Mar 21
Cardinal Health expects that the sale of the Cordis business will decrease Medical segment profit by about $60m…
01 Feb 21
DiamondTemp is indicated for the treatment of recurrent, symptomatic paroxysmal atrial fibrillation (AF) in patients who do not…
22 Jan 21
The acquisition of Preventice will provide Boston Scientific with a foothold in the high-growth ambulatory electrocardiography space
21 Dec 20
The acquisition will combine Philips’ in-hospital patient monitoring capabilities with BioTelemetry’s monitoring capabilities outside the hospital
03 Nov 20
The EnSite X EP System is an advanced cardiac mapping system designed to optimise cardiac ablation procedures in…
22 Sep 20
MitraClip G4 system is already approved for use in the US, and the regulatory approval allows its use…
07 Jul 20
Abbott’s Gallant implantable cardioverter defibrillator family of devices are capable of connecting patients and doctors via Bluetooth